Presolicitation Notice – Clinical Trials Network Clinical Laboratory Services
General Information
-
Document Type: Presolicitation Notice Solicitation Number: Reference-Number-N01DA-4-2206 Posted Date: Mar 12, 2004 Original Response Date: May 12, 2004 Current Response Date: May 12, 2004 Original Archive Date: May 27, 2004 Current Archive Date: May 27, 2004 Classification Code: A — Research & Development Naics Code: 325412 — Pharmaceutical Preparation Manufacturing
Contracting Office Address
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, IRP, 6101 Executive Blvd Room 260, Bethesda, MD, 20892-8402
Brief Description
- The National Institute on Drug Abuse (NIDA) plans to solicit proposals from qualified organizations having resources to perform clinical laboratory services to support national multi-site clinical trials. Services include supplying of clinical products to trial sites, performing laboratory analyses, evaluating devices and methodologies, and providing consultations in screening and testing methodologies used in addiction research. All laboratories must be operated according to the FDA’s Good Laboratory Practices Program and have required national certification. All operations should be performed under established Standard Operating Procedures (SOPs) and current Good Laboratory Practice (GLP) guidelines. For complete description and more information, please click on the link below:
For more information, please click on the following link:
http://www1.eps.gov/spg/HHS/NIH/NIDA/Reference%2DNumber%2DN01DA%2D4%2D2206/SynopsisP.html
